175 related articles for article (PubMed ID: 9774439)
1. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein.
Verdier F; Chrétien S; Muller O; Varlet P; Yoshimura A; Gisselbrecht S; Lacombe C; Mayeux P
J Biol Chem; 1998 Oct; 273(43):28185-90. PubMed ID: 9774439
[TBL] [Abstract][Full Text] [Related]
2. Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors.
Verdier F; Walrafen P; Hubert N; Chretien S; Gisselbrecht S; Lacombe C; Mayeux P
J Biol Chem; 2000 Jun; 275(24):18375-81. PubMed ID: 10849444
[TBL] [Abstract][Full Text] [Related]
3. A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5.
Wang D; Moriggl R; Stravopodis D; Carpino N; Marine JC; Teglund S; Feng J; Ihle JN
EMBO J; 2000 Feb; 19(3):392-9. PubMed ID: 10654938
[TBL] [Abstract][Full Text] [Related]
4. CIS1, a cytokine-inducible SH2 protein, suppresses BCR/ABL-mediated transformation. Involvement of the ubiquitin proteasome pathway.
Tauchi T; Yoshimura A; Ohyashiki K
Exp Hematol; 2001 Mar; 29(3):356-61. PubMed ID: 11274764
[TBL] [Abstract][Full Text] [Related]
5. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
Ram PA; Waxman DJ
J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors.
Callus BA; Mathey-Prevot B
Blood; 1998 May; 91(9):3182-92. PubMed ID: 9558373
[TBL] [Abstract][Full Text] [Related]
7. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
[TBL] [Abstract][Full Text] [Related]
8. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
9. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
10. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.
Matsumoto A; Masuhara M; Mitsui K; Yokouchi M; Ohtsubo M; Misawa H; Miyajima A; Yoshimura A
Blood; 1997 May; 89(9):3148-54. PubMed ID: 9129017
[TBL] [Abstract][Full Text] [Related]
11. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway.
Kim TK; Maniatis T
Science; 1996 Sep; 273(5282):1717-9. PubMed ID: 8781235
[TBL] [Abstract][Full Text] [Related]
12. Nuclear phosphatases and the proteasome in suppression of STAT1 activity in hepatocytes.
Liu D; Scafidi J; Prada AE; Zahedi K; Davis AE
Biochem Biophys Res Commun; 2002 Dec; 299(4):574-80. PubMed ID: 12459177
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin.
Yen CH; Yang YC; Ruscetti SK; Kirken RA; Dai RM; Li CC
J Immunol; 2000 Dec; 165(11):6372-80. PubMed ID: 11086075
[TBL] [Abstract][Full Text] [Related]
14. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation.
Yu CL; Burakoff SJ
J Biol Chem; 1997 May; 272(22):14017-20. PubMed ID: 9162019
[TBL] [Abstract][Full Text] [Related]
15. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
Goh EL; Zhu T; Leong WY; Lobie PE
Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl: involvement of the ubiquitin proteosome pathway.
Okabe S; Tauchi T; Morita H; Ohashi H; Yoshimura A; Ohyashiki K
Exp Hematol; 1999 Oct; 27(10):1542-7. PubMed ID: 10517496
[TBL] [Abstract][Full Text] [Related]
17. Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis.
Canu N; Barbato C; Ciotti MT; Serafino A; Dus L; Calissano P
J Neurosci; 2000 Jan; 20(2):589-99. PubMed ID: 10632588
[TBL] [Abstract][Full Text] [Related]
18. Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3.
Chin H; Nakamura N; Kamiyama R; Miyasaka N; Ihle JN; Miura O
Blood; 1996 Dec; 88(12):4415-25. PubMed ID: 8977232
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex.
Hu Z; Zhang Z; Doo E; Coux O; Goldberg AL; Liang TJ
J Virol; 1999 Sep; 73(9):7231-40. PubMed ID: 10438810
[TBL] [Abstract][Full Text] [Related]
20. The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal.
Migone TS; Humbert M; Rascle A; Sanden D; D'Andrea A; Johnston JA
Blood; 2001 Sep; 98(6):1935-41. PubMed ID: 11535532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
